2011
DOI: 10.2147/ppa.s22771
|View full text |Cite
|
Sign up to set email alerts
|

Treatment simplification in HIV-infected adults as a strategy to prevent toxicity, improve adherence, quality of life and decrease healthcare costs

Abstract: Since the advent of highly active antiretroviral therapy (HAART), the treatment of human immunodeficiency virus (HIV) infection has become more potent and better tolerated. While the current treatment regimens still have limitations, they are more effective, more convenient, and less toxic than regimens used in the early HAART era, and new agents, formulations and strategies continue to be developed. Simplification of therapy is an option for many patients currently being treated with antiretroviral therapy (A… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1
1

Citation Types

1
63
0
5

Year Published

2014
2014
2023
2023

Publication Types

Select...
8
1

Relationship

0
9

Authors

Journals

citations
Cited by 80 publications
(69 citation statements)
references
References 61 publications
1
63
0
5
Order By: Relevance
“…Patients on QD regimens were significantly more adherent. Our observations indicate that ARV side effects and regimen improvements remain major reasons driving patient discontinuation of first-round therapy in the modern HAART era and are consistent with the findings of other groups [17][18][19]. The most common reasons for treatment switch or discontinuation were consistent over time and included change in regimen with the aim of improving the ARV regimen, gastrointestinal side effects, or neuropsychological complications.…”
Section: Discussionsupporting
confidence: 87%
See 1 more Smart Citation
“…Patients on QD regimens were significantly more adherent. Our observations indicate that ARV side effects and regimen improvements remain major reasons driving patient discontinuation of first-round therapy in the modern HAART era and are consistent with the findings of other groups [17][18][19]. The most common reasons for treatment switch or discontinuation were consistent over time and included change in regimen with the aim of improving the ARV regimen, gastrointestinal side effects, or neuropsychological complications.…”
Section: Discussionsupporting
confidence: 87%
“…These results suggest that treatment discontinuation in the modern-era of ARV and challenges to drug adherence remain key clinical issues [20][21][22][23]. Nevertheless, the benefits of less frequent treatment dosing was demonstrated in this analysis as QD patients were more adherent than BID+ patients, were more likely to achieve viral suppression, and less likely to discontinue or switch their initially prescribed regimen due to viral failure [18,[24][25][26][27][28][29]. These findings are highly relevant to informing clinicians in their attempts to retain patients on effective antiretroviral 4%) did not have dosing frequency recorded and were excluded **defined as <40 copies/mL (prior to 1998 assay sensitivity for suppression was <499 copies/mL) ***n's less than the total sample size reflect missing data therapy and are a critical component of the HIV cascade of care [30,31].…”
Section: Discussionmentioning
confidence: 73%
“…[19][20] Decreasing pill burden by simplifying the ART regimen is one method used to promote ART adherence. 1,21 STRs that reduce pill burden to as little as 1 pill taken once daily have been associated with improved adherence, reduced hospitalizations, and improved viral suppression. [22][23][24][25][26] In our study, patients who received STRs were about 1.3 times more likely to be adherent (i.e., MPR ≥ 90%) than patients receiving more than 1 (N = 3,528) antiretroviral product.…”
Section: ■■ Discussionmentioning
confidence: 99%
“…Anti Retro Virus (ARV) has been proven effective to increase CD4 levels, suppress HIV viral load and improve patients' quality of life (Nachega;Mugavero;Zeier;Vitória, Gallant, 2011). From this research, ARV resulting a decrease in the morbidity and mortality of HIV/AIDS patients.…”
Section: Introductionmentioning
confidence: 99%